...
首页> 外文期刊>Journal of Clinical Microbiology >Identification and Purification of SpecificPenicillium marneffei Antigens and Their Recognition by Human Immune Sera
【24h】

Identification and Purification of SpecificPenicillium marneffei Antigens and Their Recognition by Human Immune Sera

机译:马尔尼菲青霉特异性抗原的鉴定,纯化及其对人免疫血清的识别

获取原文
           

摘要

Disseminated infection with the dimorphic pathogenic fungusPenicillium marneffei is increasingly seen among patients with AIDS in southeast Asian countries. Previous studies have demonstrated the presence of humoral immune responses to this fungus in patient sera; we have confirmed this work using sera from P. marneffei-infected patients (n = 21) to develop Western blots of P. marneffei cytoplasmic yeast antigen (CYA). P. marneffei CYA was then partially purified by liquid isoelectric focusing, and fractions were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. Immunoenzyme development of the Western blots with pooled sera from patients with P. marneffei infection and with pooled sera from patients with aspergillosis (n = 20), candidiasis (n = 10), cryptococcosis (n = 9), and histoplasmosis (n = 11) revealed three antigens with relative molecular masses of 61, 54, and 50 kDa. These antigens were specifically recognized by the pooled sera from the P. marneffei-infected patients. The 61- and 54-kDa antigens were subsequently purified to homogeneity by preparative gel electrophoresis, and the 50-kDa antigen was partially purified by the same technique. N-terminal amino acid sequencing revealed that the 61-kDa antigen had a strong homology (87% identity) with the antioxidant enzyme catalase. The three antigens were then subjected to SDS-PAGE and Western blotting and to immunoenzyme development with individual patient sera; sera from 86% of P. marneffei-infected patients recognized the 61-kDa antigen, sera from 71% recognized the 54-kDa antigen, and sera from 48% recognized the 50-kDa antigen. These specifically recognized antigens are the first to be purified from P. marneffei and can be used either singly or in combination to detect antibody responses in a large percentage of individuals infected with P. marneffei.
机译:在东南亚国家,艾滋病患者中越来越多地发现了双态病原真菌 marneffei 。先前的研究表明患者血清中存在对该真菌的体液免疫反应。我们已经使用 P的血清确认了这项工作。感染marneffei 的患者( n = 21)出现了 P的Western印迹。马尔尼菲胞质酵母抗原(CYA)。 P。然后通过液体等电聚焦法对marneffei CYA进行部分纯化,并将级分进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质印迹。合并有 P患者血清的Western印迹的免疫酶促发展。曲霉菌病( n = 20),念珠菌病( n = 10),隐球菌病( n > = 9),而组织胞浆菌病( n = 11)则显示出三种相对分子质量分别为61、54和50 kDa的抗原。这些抗原被 P的合并血清特异性识别。感染marneffei 的患者。随后通过制备性凝胶电泳将61 kDa和54 kDa抗原纯化至均质,并通过相同技术部分纯化50 kDa抗原。 N端氨基酸测序表明61 kDa抗原与抗氧化酶过氧化氢酶具有很强的同源性(87%一致性)。然后对这三种抗原进行SDS-PAGE和Western印迹,并根据患者的血清进行免疫酶的培养。血清中 P的86%。感染marneffei的患者识别出61 kDa抗原,来自71%的血清识别出54 kDa抗原,来自48%的血清识别出50 kDa抗原。这些特异性识别的抗原是第一个从 P纯化的抗原。 marneffei ,可以单独使用或组合使用,以检测 P感染的很大一部分患者的抗体反应。马尔尼菲。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号